Gulf starts at Sheikh Adi-2 25/05/2012
Iraq-focused oil explorer Gulf Keystone Petroleum (GKP) has begun drilling at the Sheikh Adi-2 well in the Sheikh Adi block.
Contract drug researcher Cyprotex (CRX) is looking for more US takeovers after annual pre-tax profits fell 56 per cent to £201,340. The Macclesfield-based company, a world leader in its field specialising in pre-clinical absorption, distribution, metabolism and excretion (ADME) assessments of new drug candidates, increased turnover 18.4 per cent to £5.9 million last year and lifted net profits 34 per cent to £617,000 after a £415,300 tax credit.
In August, AIM-quoted Cyprotex, steered by chief executive officer Dr. Anthony Baxter and chaired by Steve Harris, made a 'transformational' move into toxicology and the key US market by buying Boston-based Apredica for £2.7 million in shares and cash. Apredica was making an acquisition of its own at the time and the deal has doubled Cyprotex's product portfolio and allowed it to make a credible entry into the in vitro toxicology market.
Cyprotex does most of its business outside the sluggish UK market and argues the tough competitive climate, caused by recession and regulatory changes, could work in its favour by putting a premium on ADME, which can weed out likely failures before they enter the costly later phases of clinical development. The company, which ended 2010 with halved cash of £1 million, is on the look-out for further takeovers, particularly in West coast USA and central Europe.
Floated on AIM at 29p in 2002 and highlighted by Growth Company Investor at a depressed 3.63p a year ago, Cyprotex shares have now reached 5.25p. Hold on.
Gain instant access to some of the best-performing and fastest growing companies in the small cap arenaClick here
Advertisement
Gain instant access to some of the best-performing and fastest growing companies in the small cap arena. Sign up NOW!
This unique study analyses the shareholdings of companies listed on AIM, extracting trends including rankings of the value and number of their investments.
Please click here to order your copy of the report or call 0207 250 7056.
Informative features and research on fast-growing companies, small-cap and growth stocks, penny shares, stock market tips and share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.
If you're interested in business tax updates visit our specialist tax guide website.
Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.
Advertisement
Iraq-focused oil explorer Gulf Keystone Petroleum (GKP) has begun drilling at the Sheikh Adi-2 well in the Sheikh Adi block.
Oil giant Shell is extending its offer period for Mozambique-focused Cove Energy (COV) after having its bid trumped by Thai government-owned PTT Exploration & Production.
Kazakhstan-focused Roxi Petroleum (RXP) has declared that its NK7 well in the Galaz aea has drilled to a depth of 1,360 metres.
Steered by sector veteran Algy Cluff, North-Sea focused cash shell Cluff Natural Resources (CNR) has joined AIM.
Somalia-focused oil explorer Red Emperor Resources (RMP) has exercised its option to take part in the drilling of the Shabeel North well.
Oil concern Heritage Oil (HOIL) has reported its Miran West-3 well in Iraq could deliver 1,000 barrels per day of condensate.